chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash and bumps on chest under pectoral muscle on both sides on 1st day after vaccine. Same around neck 2nd day.; Rash and bumps on chest under pectoral muscle on both sides on 1st day after vaccine. Same around neck 2nd day.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53-year-old male patient received BNT162b2 (BNT162B2), on 13May2022 at 08:00 as dose 3 (booster), single (Lot number: FM9992) at the age of 53 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Covid-19" (unspecified if ongoing), notes: If covid prior vaccination: Yes. Concomitant medication(s) included: REMERON; ATORVASTATIN. Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: ER8732, Location of injection: Arm Left, Vaccine Administration Time: 04:00 PM), administration date: 01Apr2021, when the patient was 52-year-old, for COVID-19 Immunization; BNT162b2 (Dose Number: 1, Batch/Lot No: EN6198, Location of injection: Arm Left, Vaccine Administration Time: 03:00 PM), administration date: 11Mar2021, when the patient was 52-year-old, for COVID-19 Immunization. The following information was reported: RASH (non-serious), PAPULE (non-serious) all with onset 14May2022 at 22:00, outcome "recovered" (May2022) and all described as "Rash and bumps on chest under pectoral muscle on both sides on 1st day after vaccine. Same around neck 2nd day.". Therapeutic measures were taken as a result of rash, papule.  Additional information:No other vaccine in four weeks. Other medications in two weeks were Remeron and Atorvastatin. Antihistamine  was as treatment for adverse events until gone. There was no known allergies. Covid tested post vaccination was no. Other medical history was none.  No follow-up attempts are possible. No further information is expected.
PedvaxHIB given instead of meningococcal vaccine. Pt had no side effect or symptoms.
Red rash (itchy) at injection site (L) arm. Some bruising. Warmth at injection site. Recommended BENADRYL 25 mg PRN.
Patient had sore arm and was awakened at night. Took 3 Aspirin and went back to sleep. No problems with arm the next day.
a lot of the same symptoms from the covid virus; chills; low grade fever; everything hurt, muscles, head; everything hurt, muscles, head; everything hurt, muscles, head; tired; weak; feeling lousy; also had the breathing problem with the virus; This is a spontaneous report from a non-contactable Consumer. A female patient of an unspecified age receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) , via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation.  The patient medical history was not reported.  The patient's concomitant medications were not reported.  The patient experienced a lot of the same symptoms from the covid virus, chills, low grade fever, everything hurt, muscles, head, tired, weak, feeling lousy, also had the breathing problem with the virus on an unspecified date.  The outcome of events was unknown.  No follow-up attempts are possible; information about batch/ lot number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021101407 same reporter/drug/events, different patients
Dizziness, Headache, Myalgia, Fatigue, Injection site pain Narrative:  Other Relevant History:
On Sunday, February 21 at 07:42 AM I received a call from patient advising me she had called for an ambulance, she was awoken from her sleep with a rapid heart beat and was also suffering from shortness of breath.  Patient was taken to Hospital where she was admitted due to a Pulmonary Embolism, a small clot was found in her lung.
9 days after my 1st dose I woke up with a red blotch on my left arm where I got my Moderna vaccine, it was warm, a little painful and a little itchy. The next day my arm was tingly and slightly numb and over this past week the numbness and tingly feeling has spread to all of my arm and to my face, to my cheekbones and below. I can still feel and  move my arm and face and control my muscles, but I feel that it's now spreading to my left leg .
Myalgia, Diarrhea & Nausea Vomiting Narrative:
3 hours following vaccinations, patient developed a fine papular rash to face with mild itching, the rash resolved but he experienced facial swelling  which progressed overnight and was notable the next am. No throat, tongue or lip swelling was noted, no other rashes. He was treated with benadryl and antihistamines but facial swelling worsened and he was treated 24 hours later with a course of oral prednisone with resolution of symptoms.
Getting ready for bed, she told me that she felt dizzy and nauseated. She then said that she felt weird "all over." Her legs began to shake and then her whole body was shaking with chills. She jerked REALLY HARD and said that it felt like she had just fallen off of a building. I start to feel her legs and can immediately tell that she was running fever. While taking her temperature, under the arm, I can feel her heart "racing" hard and fast. She then starts to complain of a tummy ache. We go to the emergency room. When we get there I notice that her top lip and under her left eye started to swell. While laying in the hospital bed she says that her it was tight under her bra strap and it was getting kind of hard to breathe. Continued with 102.6 fever and vomiting and one episode of diarrhea. For the past couple of months she has complained of sensitive teeth.
fatigue; arm pain; severe pain in the deltoid; This case was reported by a other health professional and described the occurrence of fatigue in a 56-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In October 2020, the patient received the 1st dose of Shingrix (intramuscular). In October 2020, 6 hrs after receiving Shingrix, the patient experienced fatigue, pain in arm and injection site pain. On an unknown date, the outcome of the fatigue, pain in arm and injection site pain were recovered/resolved.   It was unknown if the reporter considered the fatigue, pain in arm and injection site pain to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in left deltoid and reported experiencing severe pain in the deltoid and arm pain. The pain in the deltoid and arm began shortly after receiving the shot and lasted approximately 3 days. The patient experienced fatigue that began approximately 6 hours after receiving Shingrix and lasted approximately one day and a half. The reporter did not consent to follow up.
arm was so sore, as if somebody beat me up but that's gone now; Under armpit is sore; Under armpit is a little bit swollen/ swollen lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was so sore, as if somebody beat me up but that's gone now), AXILLARY PAIN (Under armpit is sore) and LYMPHADENOPATHY (Under armpit is a little bit swollen/ swollen lymph nodes) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm was so sore, as if somebody beat me up but that's gone now), AXILLARY PAIN (Under armpit is sore) and LYMPHADENOPATHY (Under armpit is a little bit swollen/ swollen lymph nodes). At the time of the report, PAIN IN EXTREMITY (arm was so sore, as if somebody beat me up but that's gone now), AXILLARY PAIN (Under armpit is sore) and LYMPHADENOPATHY (Under armpit is a little bit swollen/ swollen lymph nodes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided.  No treatment medication were provided.
Pt brought her Vaccination Record Card where she got her first shot at the Health Department. The card had the date and facility given but did not have the specific vaccine record filled out. Pt verified when asked that her first dose had been one brand covid vaccine.  Pt was given the second vaccine. During her 15 minute wait we thought to look up on agency to fill in the Lot of her first vaccine to complete her record card. Agency had her record as one covid for her first dose however. So pt received one vaccine for her first dose and other brand vaccine as a second dose.
vaccine was not properly injected/dose was shot twice; body aches; soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness), WRONG TECHNIQUE IN DEVICE USAGE PROCESS (vaccine was not properly injected/dose was shot twice) and MYALGIA (body aches) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced PAIN (soreness) and MYALGIA (body aches). On an unknown date, the patient experienced WRONG TECHNIQUE IN DEVICE USAGE PROCESS (vaccine was not properly injected/dose was shot twice). At the time of the report, PAIN (soreness) and MYALGIA (body aches) outcome was unknown and WRONG TECHNIQUE IN DEVICE USAGE PROCESS (vaccine was not properly injected/dose was shot twice) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included blood pressure medications.   No treatment information was provided.
The patient experienced no symptoms; patient was administered an expired dose of VAQTA; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. There was no information on the patient's pertinent medical history, concomitant medications, drug reactions or allergies provided. On 01-JUN-2020, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) (exact dose not reported) intramuscularly, lot # S001485 with expiration date 12-MAY-2020. The patient did not experienced any symptoms. No product quality complaint was reported. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S001485; expirationdate: 12-MAY-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
mild fever and headache starting approximately 6 hours after injection.  100.4F by digital no-touch thermometer acquired in ear.  Fever gone  after 12 hours.  Headache gone after 18hours with 400mg Advil taken 18 hours after start of fever.
A report was received from a health care professional on 10/31/2003 concerning a 28 year old female vaccinee who inadvertently received a double dose of Fluvirin on 10/31/2003. The vaccinee had experienced no adverse reaction at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 1, 02/17/2004: A follow up report was received from a health care professional indicating that no adverse event had occurred at the time of reporting. No follow up pending, all information received. See ref: PJP200300960 and PJP200300961.
Healthy male, no substance use, no symptoms reported made plans to go hiking with a friend the following Sunday (4/18/21) on 4/16/2021 in afternoon. This was last known contact, patient stopped responding to phone after text and was found deceased in home on 4/22/2021, appearing to have passed away in sleep, likely 4/16/2021 in evening.
Itching started face, hands, back minutes after injection.  Pubic pain, pressure, frequency started that evening.  No fever, chills or other malaise.  Urinary symptoms persist at time of report 06/02/2005.  Treatment with Cipro and prosed EC 06/04/2005.
Employee complained of fatigue, elevated temperature, and swollen glands with large raised areas near back of ears. Pt seen by MD. Tylenol prescribed and blood drawn for CBC.
Bright red, swollen area warm to touch around injection area. About 2 1/2" in diameter. Lighter pink area, slightly swollen radiating from injection area about 5" from injection site to arm area above elbow.  Extremely itchy directly around injection site.
Patient passed out and fell out of the chair he was sitting in shortly after receiving the FLUCELVAX 2018-2019 vaccination. During the fall he hit his head on a sunglasses display. Patient came too about 5-10 seconds later and was very confused and in a state of shock. We got him back sitting in the chair and explained to him what had happened. He did not remember falling but was quickly able to recognize his girlfriend and understand what happened. He was very flushed after and seemed sluggish. He sat down for about 30 minutes and refused any medical services. He was able to eventually get up and walk out to his car and felt ok.
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 05-DEC-2015 at time- 15:18, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # L025738 (expiry date, dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse events were reported. The high temperature and low temperature at which the product was stored were 2.8 and 2.4 (units unspecified) respectively. There were no Product Quality Complaint (PQC) involved. This is one of the several reports received from same reporter. Additional information has been requested.
TREMORS/SHAKING; WAIST PAIN; COULDN'T WALK; FEELS AWFUL/TERRIBLE; HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry date: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. The batch number was not reported and has been requested.  On 08-APR-2021, the subject experienced tremors/shaking. On 08-APR-2021, the subject experienced waist pain. On 08-APR-2021, the subject experienced couldn't walk. On 08-APR-2021, the subject experienced feels awful. On 08-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, and the outcome of tremors/shaking, waist pain, couldn't walk and feels awful was not reported. This report was non-serious.
This spontaneous report as received from a pharmacist refers to a 51 year old female patient. On 01-MAY-2013, the patient was vaccinated with a dose of ZOSTAVAX, lot # J000492, expiration date January 2014, 0.65 ml, subcutaneous. The patient experienced a mild case of shingles, after receiving ZOSTAVAX in May 2013 and a second episode of shingles in August 2013. The patient was treated with acyclovir. The outcome of the events was unknown. Additional information has been requested.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown demographics. Information regarding the patient's concurrent conditions, medical history and concomitant medications was not provided. On an unknown dates the patient was vaccinated with a improperly stored dose of RECOMBIVAX HB which had a lot number of L038018 with expiration date on 13-SEP-2017 (dose, route of administration and anatomical location were not reported) for prophylaxis. No adverse effects were reported. No product quality complaint was involved. This is one of several reports received from the same source. As, on 09-DEC-2016, all telephone attempts to obtain follow up information have been unsuccessful. Additional information has been requested. The narrative was updated. Sender's Comments: US-009507513-1610USA003123: MERCK 1611USA000313:Mfr number.
This non-serious spontaneous case, was initially received on 14-Aug-2017 from physician, concerning a 11-year-old, female child. On 11-Apr-2017, the patient was administered with FLUCELVAX QIV (batch number: 185686 (reported as 185586, 186686), expiry date: 31-May-2017, dose, route of administration, anatomical location: not reported). It was reported, that multiple temperature excursions occurred on 02-Mar-2017, as the vaccine was stored at 47F for 14.7h (1st excursion), 03-Mar-2017 at 47F for 16h (2nd excursion), 04-Mar-2017 at 47F for 19.75h (3rd excursion), 07-Apr-2017 at 35F for 14.5h which was considered as incorrect product storage. The patient was administered with vaccine which was stored at 46F to 77F up to 24 hours instead of storing at 36-46F it was considered as drug administration error. The outcome of the events was not reported. The reporter did not provide the seriousness assessment. Non-significant case correction received 14-Aug-2017: Batch no. (185686) was captured in the case form and narrative was amended accordingly.
97.9 right 18 pounds. Patient given MMRV and HIB. Grandmother states after 1 hour getting home cheeks were red. Around 9:30pm neck was itchy and red, face red, whole body was red and itchy. Went to ER give Benadryl by mouth. At 5am on 12/12/06 rash a little better. 10am most of rash gone. Patient had a follow up appointment in clinic on 12/12/06. Skin is still red on exam.
vasovagal response shortly after sitting down in observation area.  pt was placed safely on floor, feet raised and regained alertness. 911 was called, vitals including Blood pressure, heart rate and alertness and orientation were monitored every 2 mins.  pt was improved shortly after feet raised. the patient later returned to the pharmacy ( 2 hours later) saying he is fine, and was told his anxiety caused the event.   pt did not go to the hospital.
Initial report received from a consumer on 29 May 2012. A 2-month-old male patient with no known allergies or any medical history and whose concomitant medication were not reported, received a dose of PENTACEL (Lot number, route and site of vaccination not reported) on 1 December 2012. On the same day, he also received a dose PREVNAR (Lot number, route and site of vaccination not reported). On an unspecified date, within 1 week post vaccination, the patient developed cluster rash on both legs. Corrective medication was not reported. The event had recovered in approximately 2 weeks. The same patient was given a dose of PENTACEL intramuscularly (Lot number and site of vaccination not reported) and PREVNAR 13 at an age of 4 months. He again developed generalized rash throughout the body. The child was evaluated by a dermatologist and was diagnosed to be suffering with atopic dermatitis with infantile eczema. He was being treated with corticosteroid cream. As of 29 May 2012, the child had not recovered from the events. List of documents held by sender: none.
It started off with a dry, hacking cough for a couple days. My wife and I took a home COVID-19 test which came back positive on 02/08/2023. Days later, it progressed to aches, pains, and a high-grade fever for one day that broke pretty fast. Later that evening, the pain got progressively worse so I went to urgent care. The nurse checked me over and prescribed me molnupiravir 4 tablets twice a day for 5 days. I tested again about three days after finishing the prescription and finally tested negative. Now, I'm doing perfectly well and better.
Delayed response (of about 6-weeks) between 2nd vaccine and immune response.  Averse event in the form of rash on back up upper arms (between shoulder and elbow). Rash was red and raised, slightly itchy. Benadryl was taken at home.  Two days later, I experienced numbness and tingling on the right side of my face.  I was directed to the ER. CT scan as done (normal), stroke ruled out, and prednisone given. 20 mg tablets/3 taken at once/ once a day for 5 days. Numbness and tingling subsided, rash no longer raised but still splotchy. Off prednisone now and tingling has returned.
Information has been received from a pharmacist concerning a female child who was vaccinated on an unspecified date with a dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live (second generation). Subsequently, the child developed arthritis pain. Unspecified medical attention was sought. The patient outcome is unknown. Additional information has been requested.
"Moderna Arm." 8 days after injection, I got a raised, red welt about 4 inches in radius that was extremely itchy. Cleared up 4 days after.
MD informed pt t105.2 the evening p/immun & pt was fussy & irritable, t102 to 105 x 2 days;
Patient says arm hurts to move up and away from body and has had ever since vaccination. Patient has not been seen by MD yet. I encouraged her to go to the doctor to get it check out. No outward signs or symptoms just the muscle pain.